肌肉来源米色脂肪前体细胞分泌促肌生成外泌体治疗小鼠肩袖肌肉变性并在人类中通过单细胞RNA测序鉴定
该研究从小鼠肌肉中分离UCP1报告基因标记的纤维脂肪生成祖细胞(FAPs),按UCP1信号强度分为UCP1-、UCP1+和UCP1++三个亚群,发现UCP1++细胞具有米色脂肪特征并分泌外泌体(Exo-FB),Exo-FB在体外促进肌管融合,在体内减轻肩袖撕裂后的肌肉萎缩和脂肪浸润;单细胞RNA测序在人类肩袖FAPs中鉴定出转录组相似的UCP1+米色脂肪细胞亚群。
要点
- UCP1++ FAP-BAT细胞高表达线粒体基因、BAT标志物和外泌体表面标志物。
- Exo-FB促进C2C12细胞肌管融合,而Exo-nFB作用差。
- Exo-FB治疗减轻小鼠肩袖损伤后肌肉萎缩和脂肪浸润。
核心结论
- FAP-BAT细胞是FAPs的一个亚群,具有上调的米色基因表达和外泌体产生,在体外和体内介导促肌生成效应,并且在人类中以转录组相似的FAPs亚群存在。
研究设计与样本
- 控制性实验室研究;从UCP1报告小鼠中通过荧光激活细胞分选分离FAPs,按UCP1信号强度分选为UCP1-、UCP1+和UCP1++;对三个亚群进行批量RNA测序;使用 cushioned-density gradient ultracentrifugation 从UCP1++ FAP-BAT细胞(Exo-FB)和UCP1-非FAP-BAT细胞(Exo-nFB)收集外泌体,处理C2C12细胞和小鼠胚胎成纤维细胞;用Exo-FB和Exo-nFB治疗经历大规模肩袖撕裂的野生型C57B/L6J小鼠,6周后处死分析冈上肌;对人类肌肉来源的FAPs用β受体激动剂福莫特罗或标准培养基处理后进行单细胞RNA测序。
主要发现
- 流式细胞术分析显示UCP1报告小鼠FAPs的UCP1信号强度呈三峰分布,与批量RNA测序鉴定的3种不同转录组谱相关。
- UCP1++细胞以高线粒体基因表达、BAT标志物和外泌体表面标志物为特征;UCP1-细胞以纤维化标志物为特征;UCP1+细胞以白色脂肪组织标志物的差异富集为特征。
- Exo-FB处理C2C12细胞导致强烈的肌管融合,而处理小鼠胚胎成纤维细胞导致分化为肌管;Exo-nFB处理细胞导致肌管形成差。
- 与Exo-nFB或磷酸盐缓冲液治疗相比,在肩袖损伤时用Exo-FB治疗的小鼠表现出显著减少的肌肉萎缩和脂肪浸润。
- 人类肩袖FAPs的单细胞RNA测序显示6个不同的人类FAPs亚群,其中一个亚群显示存在UCP1+米色脂肪细胞,具有BAT、线粒体和细胞外囊泡相关标志物的独特谱。
临床怎么用
- 作者指出FAP-BAT细胞及其外泌体代表治疗肩袖肌肉变性的潜在治疗途径。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Muscle atrophy, fibrosis, and fatty infiltration are common to a variety of sports-related and degenerative conditions and are thought to be irreversible. Fibroadipogenic progenitors (FAPs) are multipotent resident muscle stem cells with the capacity to differentiate into fibrogenic as well as white and beige adipose tissue (BAT). FAPs that have assumed a BAT differentiation state (FAP-BAT) have proven efficacious in treating muscle degeneration in numerous injury models. PURPOSE: To characterize the subpopulation of murine FAPs with FAP-BAT activity, determine whether their promyogenic effect is mediated via exosomes, and analyze human FAPs for an analogous promyogenic exosome-rich subpopulation. STUDY DESIGN: Controlled laboratory study. METHODS: FAPs from UCP1 reporter mice were isolated via fluorescence-activated cell sorting and sorted according to the differential intensity of the UCP1 signal observed: negative for UCP1 (UCP1-), intermediate intensity (UCP1+), and high intensity (UCP1++). Bulk RNA sequencing was performed on UCP1-, UCP1+, and UCP1++ FAPs to evaluate distinct characteristics of each population. Exosomes were harvested from UCP1++ FAP-BAT exosomes (Exo-FB) as well as UCP1- non-FAP-BAT exosomes (Exo-nFB) cells using cushioned-density gradient ultracentrifugation and used to treat C2C12 cells and mouse embryonic fibroblasts in vitro, and the myotube fusion index was assessed. Exo-FB and Exo-nFB were then used to treat wild type C57B/L6J mice that had undergone a massive rotator cuff tear. At 6 weeks mice were sacrificed, and supraspinatus muscles were harvested and analyzed for muscle atrophy, fibrosis, fatty infiltration, and UCP1 expression. Single-cell RNA sequencing was then performed on FAPs isolated from human muscle that were treated with the beta-agonist formoterol or standard media to assess for the presence of a parallel promyogenic subpopulation of FAP-BAT cells in humans. RESULTS: Flow cytometry analysis of sorted UCP1 reporter mouse FAPs revealed a trimodal distribution of UCP1 signal intensity, which correlated with 3 distinct transcriptomic profiles characterized with bulk RNA sequencing. UCP1++ cells were marked by high mitochondrial gene expression, BAT markers, and exosome surface makers; UCP1- cells were marked by fibrogenic markers; and UCP1+ cells were characterized differential enrichment of white adipose tissue markers. Exo-FB treatment of C2C12 cells resulted in robust myotube fusion, while treatment of mouse embryonic fibroblasts resulted in differentiation into myotubes. Treatment of cells with Exo-nFB resulted in poor myotube formation. Mice that were treated with Exo-FB at the time of rotator cuff injury demonstrated markedly reduced muscle atrophy and fatty infiltration as compared with treatment with Exo-nFB or phosphate-buffered saline. Single-cell RNA sequencing of human FAPs from the rotator cuff revealed 6 distinct subpopulations of human FAPs, with one subpopulation demonstrating the presence of UCP1+ beige adipocytes with a distinct profile of BAT, mitochondrial, and extracellular vesicle-associated markers. CONCLUSION: FAP-BAT cells form a subpopulation of FAPs with upregulated beige gene expression and exosome production that mediate promyogenic effects in vitro and in vivo, and they are present as a transcriptomically similar subpopulation of FAPs in humans. CLINICAL RELEVANCE: FAP-BAT cells and their exosomes represent a potential therapeutic avenue for treating rotator cuff muscle degeneration.
引用
- Davies MR, Garcia S, Liu M, et al. Muscle-Derived Beige Adipose Precursors Secrete Promyogenic Exosomes That Treat Rotator Cuff Muscle Degeneration in Mice and Are Identified in Humans by Single-Cell RNA Sequencing. Am J Sports Med. 2022. PMID: 35604307. doi:10.1177/03635465221095568
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。